Successful US field trials in cotton, soybeans and cucurbits MustGrow’s mustard-based technology showed efficacy comparable to synthetic chemical standards for
Read MoreField data confirmed reduced incidence and severity of Fusarium wilt TR4 symptoms in banana plants after application of MustGrow’s product.
Read More07 November 2021, Canada: MustGrow Biologics Corp. is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its
Read More10 October 2021, Canada: MustGrow Biologics Corp. is pleased to announce the closing of its previously-announced non-brokered private placement (the
Read More29 September 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce it has upsized its
Read More13 September 2021, Canada: MustGrow Biologics Corp. is pleased to announce a non-brokered private placement of approximately 770,000 units for gross
Read More04 August 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) and Sumitomo Corporation (TYO: 8053) (OTC: SSUMY) have signed an Exclusive
Read MoreWork completed under non-exclusive agreement with Gowan Group’s biological division Ecoflora Agro in Colombia. MustGrow and Gowan reported control of Fusarium disease in carnation
Read More12 July 2021, Canada: MustGrow Biologics Corp. is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores
Read More03 March 2021, Canada: MustGrow Biologics Corp. is pleased to announce that it has isolated and concentrated an additional molecule, thiocyanate,
Read More
